This is a preprint.
COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
- PMID: 32601612
- PMCID: PMC7316095
- DOI: 10.26434/chemrxiv.12462623
COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
Update in
-
COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database.Bioinformatics. 2021 May 1;37(4):586-587. doi: 10.1093/bioinformatics/btaa718. Bioinformatics. 2021. PMID: 33175089 Free PMC article.
Abstract
In response to the COVID-19 pandemic, we established COVID-KOP, a new knowledgebase integrating the existing ROBOKOP biomedical knowledge graph with information from recent biomedical literature on COVID-19 annotated in the CORD-19 collection. COVID-KOP can be used effectively to test new hypotheses concerning repurposing of known drugs and clinical drug candidates against COVID-19. COVID-KOP is freely accessible at <a href="https://covidkop.renci.org/">https://covidkop.renci.org/</a>. For code and instructions for the original ROBOKOP, see: https://github.com/NCATS-Gamma/robokop.
Keywords: CORD-19; COVID-19; Drug Repurposing; Drug-target-disease associations; Knowledge Graph; Web-server; database mining.
Conflict of interest statement
No conflicts of interest.
Figures
References
-
- Ashburner M.; Ball C. A.; Blake J. A.; Botstein D.; Butler H.; Cherry J. M.; Davis A. P.; Dolinski K.; Dwight S. S.; Eppig J. T.; Harris M. A.; Hill D. P.; Issel-Tarver L.; Kasarskis A.; Lewis S.; Matese J. C.; Richardson J. E.; Ringwald M.; Rubin G. M.; Sherlock G. Gene Ontology: Tool for the Unification of Biology. Nat. Genet. 2000, 25, 25–29. - PMC - PubMed
-
- Scott L. J. Linagliptin: In Type 2 Diabetes Mellitus. Drugs 2011, 71, 611–624. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources